Kaerus Bioscience’s lead candidate KER-0193 granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA for treatment of Fragile X syndrome (FXS)
                                    FDA’s two designations demonstrate KER-0193’s potential as a treatment for FXS Follows the successful completion of Phase 1 clinical trial Fragile X... Read more.                                
                            
                                                            
                            
                            
                            
                        
                                                    Google Cloud and Philips Collaborate to Drive Consumer Marketing Innovation and Transform Digital Asset Management with AI
                                    Google Cloud helps streamline marketing processes, enhancing brand consistency and reducing operational costs AMSTERDAM and SUNNYVALE, Calif., May 14, 2025 /PRNewswire/... Read more.                                
                            
                                                            
                            
                            
                            
                        
                                                    Euroclear reports strong business income growth in Q1 2025
                                    BRUSSELS, May 14, 2025 /PRNewswire/ — Results for the first quarter ending 31 March 2025 Financial highlights Strong underlying business growth offsetting... Read more.                                
                            
                                                            
                            
                            
                            
                        
                                                    Safeture Signs Two-Year Global Partnership with Amadeus
                                    LUND, Sweden, May 14, 2025 /PRNewswire/ — Safeture AB, a Swedish leading provider of people risk management technology, has signed a two-year partnership agreement... Read more.                                
                            
                                                            
                            
                            
                            
                        
                                                    Hansa Biopharma data at the 2025 PNS Annual Meeting demonstrates potential of imlifidase in the treatment of GBS
                                    LUND, Sweden, May 14, 2025 /PRNewswire/ — Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), will present data from its 15-HMedIdeS-09 Phase... Read more.                                
                            
                                                            
                            
                            
                            
                        
                                                    Gentoo Media Inc. publishes Q1 2025 Interim Report: Strategic initiatives lay foundation for long-term growth
                                    ST. JULIANS, Malta, May 14, 2025 /PRNewswire/ — Gentoo Media today announces its interim results for the first quarter of 2025. The quarter marked a transitional... Read more.                                
                            
                                                            
                            
                            
                            
                        
                                                    Julius Clinical and Peachtree BioResearch Solutions Merge to Form a Fully Integrated Global CRO with Increased CNS Capabilities
                                    ZEIST, Netherlands, May 14, 2025 /PRNewswire/ — Julius Clinical, a leading full-service Contract Research Organization (CRO) headquartered in the Netherlands... Read more.                                
                            
                                                            
                            
                            
                            
                        
                                                    Denver Post Names Vectra Bank Colorado A Winner of the State of Colorado Top Workplaces 2025 Award
                                    DENVER, May 14, 2025 /PRNewswire/ – Vectra Bank Colorado has been awarded a Top Workplaces 2025 honor by Colorado Top Workplaces. This list is based solely... Read more.                                
                            
                                                            
                            
                            
                            
                        
                                                    Broadridge Announces New Patent on Large Language Model Orchestration of Machine Learning Agents
                                    NEW YORK, May 14, 2025 /PRNewswire/ — Broadridge Financial Solutions Inc. (NYSE:BR) has been awarded a new U.S. patent on its large language model (LLM)... Read more.                                
                            
                                                            
                            
                            
                            
                        
                                                    Caliway Announces Successful EOP2 Meeting with the FDA for CBL-514 in Reduction of Abdominal Subcutaneous Fat
                                    Caliway has completed the End-of-Phase 2 (EOP2) meeting with the U.S. FDA for CBL-514, the world’s first investigational drug for large-area subcutaneous fat... Read more.